Please come meet Porton Advanced │ Cell & Gene Therapy CDMO/CRO this Thursday at the BVS and Bonneville Labs BI(O)LYMPICS Event! Date & Time: 8/1/24 between 4:30-7:00 pm PST Venue: Bonneville Labs Address: Parking Lot 626 Bancroft Way Berkeley, CA 94710 There will be vendor exhibits, great food, beer, wine, lots of networking, and lab tours with a chance to meet with some great professionals within the biotech community. Come join us! You may pre-register using the QR code below:
Porton Advanced │ Cell & Gene Therapy CDMO/CRO
Pharmaceutical Manufacturing
Cranbury, New Jersey 1,424 followers
End-to-end cell & gene therapy CDMO/CRO that provides innovative offerings at each stage for biopharmaceutical products.
About us
Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP manufacturing, and testing services of AAV, Lentivirus, mRNA, and plasmid to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages. Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes. Our services include gene and cell engineering discovery research and technology licensing, process development and analytical development, testing, drug substances (DS) and drug products (DP), and cGMP manufacturing across plasmids, cell therapy, gene therapy, virotherapy, and mRNA-based therapeutic platforms. Contact us Business inquiry and collaboration Email: info@portonadvanced.com Visit our website to find out how Porton Advanced help sponsors to advance their programs.
- Website
-
http://www.portonadvanced.com
External link for Porton Advanced │ Cell & Gene Therapy CDMO/CRO
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Cranbury, New Jersey
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
6 Cedar Brook Dr
Cranbury, New Jersey 08512, US
-
Building 3, Ascendas Park, No.388 Xinping Street, Suzhou Industrial Park
Suzhou, Jiangsu 215021, CN
Employees at Porton Advanced │ Cell & Gene Therapy CDMO/CRO
Updates
-
Porton Advanced │ Cell & Gene Therapy CDMO/CRO reposted this
Porton J-STAR Research, Inc. is at the forefront of GMP drug product clinical manufacturing, ensuring that every product from our facility meets the highest quality and safety standards. Under the leadership of Dr. Hugh Huang, our drug product development and manufacturing teams prioritize science-based formulation development and robust process design to deliver client-focused cGMP manufacturing projects quickly and reliably. Reach out to our team at business@portonusa.com to connect with our scientists to discuss how Porton Pharma Solutions Ltd./J-STAR Research, Inc. can help you. Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #healthcare #Porton #drugproduct #coprocessing #smallmolecules #API #manufacture #customerfocus
-
👏 🎉We would like to congratulate Tr1X Bio for announcing their very first patient in the TRX103-01 proof of concept trial for prevention of Graft versus Host Disease (GvHD)! TRX103 is a First-in-Class Type 1 Treg (Tr1) Cell Therapy, “designed to reset the immune system, improve clinical outcomes, and potentially cure patients suffering from autoimmune and inflammatory disorders.” Read more here: https://lnkd.in/g9MbUfWP #CDMO #GMP #CART #Treg #Lentivirus #Plasmid #PortonAdvanced #Tr1XBio
-
🔍 Discover Lentivirus Solutions with Porton Advanced │ Cell & Gene Therapy CDMO/CRO! At Porton Advanced, we're dedicated to advancing your research through our comprehensive lentivirus services. Here's how we can support your projects: 1. Custom Lentiviral Vectors: Tailored to meet your specific research needs, our custom vectors ensure precise genetic delivery for a range of applications. 2. CDMO Services: From vector design to large-scale/GMP production, our CDMO services are built on cutting-edge technology and expert insights, ensuring reliable results at every stage. 3. Lentiviral Helper Plasmids: Registered with CBER FDA Drug Master Files #29485, #29473, and #29421, our three lentiviral helper plasmids support your FDA IND applications, simplifying regulatory documents. What sets us apart? ✨ Innovative Technology: Leveraging the latest advancements in lentiviral research to provide you with state-of-the-art solutions. 🔬 Scientific Expertise: Our team of researchers and scientists are committed to delivering high-quality vectors and services, backed by rigorous quality control measures. 🌍 Global Reach: Serving researchers worldwide, we're your partner in accelerating discoveries across diverse scientific fields. Whether you're in academia or industry, Porton Advanced is here to empower your research journey with trusted lentivirus solutions. Visit our website to learn more and transform your ideas into impactful discoveries: CDMO - https://lnkd.in/eUdiQnGv CRO - https://lnkd.in/e3meyYpf #Lentivirus #ViralVector #Lenti #CDMO #CRO #PortonAdvanced
Lentivirus
https://portonadvanced.com
-
Please come meet Porton Advanced │ Cell & Gene Therapy CDMO/CRO today at the Bio-EV Vendor Showcase at Valley Research Park! 6/27/2024 at 1:00-3:00 pm PST Venue: Valley Research Park 319 N. Bernardo Ave. Mountain View, CA We look forward to seeing you there! You may pre-register using the QR code below:
-
🔬Check out this exciting CAR-T news! 🌟 An 11-year-old leukemia survivor is thriving after going through CAR-T treatment. "What CAR T-cell therapy does, is it takes the patient's T-cells from their body, not all of them, but just a little sampling, and then reengineers them, or reprograms them, so they can recognize the cancer cell as being bad," Dr. Gardner states. https://lnkd.in/dEPbjd6U 🧬Porton Advanced │ Cell & Gene Therapy CDMO/CRO offers CAR-T and various other cell therapies. Please contact us to learn more about our cell therapy services: https://lnkd.in/gge_QVR8
11-year-old cancer survivor thriving after CAR-T treatment
msn.com
-
🌟 Exciting Cell Therapy News from Porton Advanced! 🌟 Porton Advanced is thrilled to announce the addition of the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to our cell therapy platform. As the first cell therapy CDMO in China to adopt this advanced system, we are enhancing our capabilities in high-efficiency, scalable transfection from research to clinical production. This allows us to provide advanced process development and production services for cell therapy projects at various stages, including IIT, IND application, and clinical trials. By introducing the MaxCyte GTx technology, Porton Advanced has further strengthened its capabilities in non-viral electroporation while empowering and accelerating the translation of gene and cell therapy drugs from the lab to the clinic and, ultimately, to the market. Join us in driving innovation in cell therapy! 🔬 Learn more here: https://lnkd.in/dXDnceiy #IND #IIT #CellTherapy #PortonAdvanced #MaxCyte #GTxFlow #GeneTherapy #mRNA #Lentivirus #Plasmid #GMP #CMC
-
💡Are you interested in Investigator-Initiated Clinical Trials (IIT)? Look no further! Porton Advanced has completed multiple IIT projects and has a proven 100% success rate for over 50 batches. 🏢 Porton Advanced Solutions LLC is headquartered in NJ, USA and offers state-of-the-art GMP facilities in Suzhou, China totaling to an impressive 215,000 square feet with many independent suites tailored to your needs. 🔬 You may opt to conduct both Investigator-Initiated Trials (IIT) and Investigational New Drug (IND) in China, while simultaneously applying for both NMPA’s and FDA’s IND approvals. This offers our clients substantial cost and time savings. We have now successfully helped our clients obtain 8 NMPA, 4 FDA, and 1 Medsafe IND approval. We can assist with: 📄 Document preparation, submission, and approval from local authorities 🤝 Connecting with local authorities and medical institutions 📝 Supporting the review of IIT study protocols 📚 Preparing documents as a CDMO partner to medical institutions for project approval and National Health Care (NHC) registry review 🔍 Finding reliable CRO and medical writing partners Please contact us to learn more! https://lnkd.in/gge_QVR8
Contact us
https://portonadvanced.com
-
Please come meet Porton Advanced │ Cell & Gene Therapy CDMO/CRO at the BVS Biotech Community Event with SOVA Science District! 6/11/2024 at 4:30-7:00 pm PST Venue: 11545 Sorrento Valley Rd. San Diego, CA (Next to New English Brewing) We look forward to seeing you there! You may pre-register using the QR code below:
-
Porton Advanced together with strategic collaborator BioMap unveiled two abstracts of Large Language Models improving AAV Capsid design at #ASGCT2024. Also, we extend our gratitude to all the friends/customers who have shown interest in us. We are thrilled to engage in discussions about how we can assist our clients in plasmid, lentiviral vector, adeno-associated viral vector, mRNA, investigator-initiated clinical trials (IIT), and more... Contact us: https://lnkd.in/gge_QVR8 #ASGCT2024 #PortonAdvanced #CellTherapy #GeneTherapy #CGT #Lentivirus #mRNA #Plasmid #CRO #CDMO